Citation analysis for PharmacoEconomics / Springer

Citation Profile [Updated: 2024-03-05 07:42:34]

5 Years H Index

Impact Factor (IF)

0.1

5 Years IF

0.15

Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators

Raw Data

	IF	AIF	CIF	IF5	DOC	CDO	CIT	NCI	CCU	D2Y	C2Y	D5Y	C5Y	SC	%SC	CiY	II	AII
1997	0	0.24	0	0	10	10	17		0	0		0			0		0	0.11
1998	0	0.28	0	0	12	22	8		0	10		10			0		0	0.13
2000	0	0.36	0.03	0.05	9	31	15	1	6	12		22	1		0		0	0.16
2001	0	0.38	0.09	0.1	3	34	4	3	9	9		31	3	2	66.7		0	0.17
2003	0	0.44	0.1	0.08	5	39	13	4	16	3		24	2	1	25		0	0.22
2004	0.2	0.49	0.08	0.12	1	40	3	3	19	5	1	17	2		0		0	0.22
2005	0.17	0.51	0.04	0.06	7	47	14	2	21	6	1	18	1		0		0	0.23
2006	0	0.5	0.17	0.13	62	109	124	18	39	8		16	2	15	83.3	13	0.21	0.22
2007	0.09	0.46	0.08	0.09	38	147	93	12	51	69	6	75	7	5	41.7	2	0.05	0.2
2008	0.07	0.49	0.07	0.08	22	169	260	11	62	100	7	113	9	4	36.4		0	0.23
2009	0.18	0.48	0.11	0.13	28	197	81	22	84	60	11	130	17	8	36.4	1	0.04	0.24
2010	0.42	0.48	0.22	0.26	33	230	79	50	134	50	21	157	41	11	22		0	0.21
2011	0.16	0.52	0.18	0.17	32	262	122	48	182	61	10	183	32	16	33.3	5	0.16	0.24
2012	0.42	0.52	0.36	0.39	93	355	180	128	310	65	27	153	60	64	50	26	0.28	0.22
2013	0.32	0.56	0.28	0.32	96	451	432	126	436	125	40	208	66	37	29.4	28	0.29	0.24
2014	0.2	0.55	0.2	0.19	110	561	353	112	548	189	37	282	54	29	25.9	18	0.16	0.23
2015	0.31	0.55	0.29	0.28	105	666	343	191	739	206	64	364	103	31	16.2	16	0.15	0.23
2016	0.28	0.53	0.26	0.28	133	799	255	206	945	215	61	436	121	36	17.5	12	0.09	0.21
2017	0.29	0.55	0.27	0.26	116	915	261	250	1196	238	68	537	138	60	24	28	0.24	0.21
2018	0.27	0.56	0.29	0.31	128	1043	168	303	1499	249	67	560	174	40	13.2	13	0.1	0.24
2019	0.3	0.58	0.32	0.27	132	1175	191	377	1876	244	72	592	162	60	15.9	35	0.27	0.23
2020	0.23	0.7	0.33	0.29	118	1293	73	424	2300	260	61	614	178	34	8	14	0.12	0.33
2021	0.23	0.84	0.31	0.24	114	1407	50	434	2734	250	58	627	149	38	8.8	18	0.16	0.31
2022	0.21	0.93	0.28	0.25	120	1527	20	422	3156	232	48	608	149	25	5.9	22	0.18	0.28
2023	0.1	1.04	0.17	0.15	86	1613	4	281	3437	234	23	612	90	8	2.8	3	0.03	0.28

IF:	Two years Impact Factor: C2Y / D2Y
AIF:	Average Impact Factor for all series in RePEc in year y
CIF:	Cumulative impact factor
IF5:	Five years Impact Factor: C5Y / D5Y
DOC:	Number of documents published in year y
CDO:	Cumulative number of documents published until year y
CIT:	Number of citations to papers published in year y
NCI:	Number of citations in year y
CCU:	Cumulative number of citations to papers published until year y
D2Y:	Number of articles published in y-1 plus y-2
C2Y:	Cites in y to articles published in y-1 plus y-2
D5Y:	Number of articles published in y-1 until y-5
C5Y:	Cites in y to articles published in y-1 until y-5
SC:	selft citations in y to articles published in y-1 plus y-2
%SC:	Percentage of selft citations in y to articles published in y-1 plus y-2
CiY:	Cites in year y to documents published in year y
II:	Immediacy Index: CiY / Documents.
AII:	Average Immediacy Index for series in RePEc in year y

50 most cited documents in this series

#	Year	Title	Cited
1	2013	Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Greenberg, Dan ; Carswell, Chris ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. Full description at Econpapers \|\| Download paper	241
2	2008	Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers \|\| Download paper	194
3	2014	Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino ; Moro, Domenico ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902. Full description at Econpapers \|\| Download paper	85
4	2019	Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Vass, Caroline ; Ellis, Alan R ; Bekker-Grob, Esther W ; Soekhai, Vikas. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2. Full description at Econpapers \|\| Download paper	71
5	2017	Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4. Full description at Econpapers \|\| Download paper	63
6	2016	Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9. Full description at Econpapers \|\| Download paper	44
7	2015	The Epidemiology of Obesity: A Big Picture. (2015). Hruby, Adela ; Hu, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:673-689. Full description at Econpapers \|\| Download paper	41
8	2015	The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Suhrcke, Marc ; Archangelidi, Olga ; Seuring, Till. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831. Full description at Econpapers \|\| Download paper	35
9		Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33. Full description at Econpapers \|\| Download paper	33
10	2014	A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170. Full description at Econpapers \|\| Download paper	32
11	2013	How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119. Full description at Econpapers \|\| Download paper	31
12	2014	Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965. Full description at Econpapers \|\| Download paper	30
13	2016	EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark ; Luo, Nan. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1. Full description at Econpapers \|\| Download paper	28
14	2012	Golimumab for the Treatment of Psoriatic Arthritis. (2012). Sculpher, Mark ; EPSTEIN, DAVID ; Bruce, Ian ; Yang, Huiqin ; Craig, Dawn ; Woolacott, Nerys ; Bojke, Laura ; Light, Kate . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:4:p:257-270. Full description at Econpapers \|\| Download paper	26
15	2015	Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Meyerhoefer, Chad ; Cawley, John ; Biener, Adam ; Hammer, Mette ; Wintfeld, Neil . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722. Full description at Econpapers \|\| Download paper	26
16	2009	Cost Effectiveness in Low- and Middle-Income Countries. (2009). Walker, Damian ; Goodman, Catherine ; Mills, Anne ; Shillcutt, Samuel . In: PharmacoEconomics. RePEc:spr:pharme:v:27:y:2009:i:11:p:903-917. Full description at Econpapers \|\| Download paper	25
17	2015	The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration. (2015). Gray, Alastair ; Froud, Robert ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver ; Petrou, Stavros ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:993-1011. Full description at Econpapers \|\| Download paper	23
18	2014	How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. Full description at Econpapers \|\| Download paper	23
19	2017	The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta ; Oliva-Moreno, Juan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y. Full description at Econpapers \|\| Download paper	21
20	2014	Preferences for Oral Anticoagulants in Atrial Fibrillation: a BestâBest Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127. Full description at Econpapers \|\| Download paper	19
21	2015	A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028. Full description at Econpapers \|\| Download paper	19
22	2014	Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime ; Neasham, David ; Lanitis, Tereza . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365. Full description at Econpapers \|\| Download paper	18
23	2014	The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86. Full description at Econpapers \|\| Download paper	18
24	2018	German Value Set for the EQ-5D-5L. (2018). Graf von der Schulenburg, Johann ; Greiner, Wolfgang ; J-Matthias Graf von der Schulenburg, ; Ludwig, Kristina. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8. Full description at Econpapers \|\| Download paper	18
25	2018	Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Cheng, Terence ; Ali, Hossein Haji ; Edney, Laura Catherine ; Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2. Full description at Econpapers \|\| Download paper	17
26	2011	Do Productivity Costs Matter?. (2011). Brouwer, Werner ; Krol, Marieke ; Koopmanschap, Marc ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:601-619. Full description at Econpapers \|\| Download paper	17
27	2015	Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135. Full description at Econpapers \|\| Download paper	17
28	2015	Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Arnberg, Karl ; Nilsson, Fredrik. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236. Full description at Econpapers \|\| Download paper	17
29	2017	International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Hout, Ben ; Chevrou-Severac, Helene ; Zouraq, Ismail Azzabi ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y. Full description at Econpapers \|\| Download paper	16
30	2018	A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D. (2018). Feng, You-Shan ; Kohlmann, Thomas ; Janssen, Mathieu F ; Buchholz, Ines. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0642-5. Full description at Econpapers \|\| Download paper	16
31	2015	Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Crausaz, Steffan ; Clement, Fiona ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924. Full description at Econpapers \|\| Download paper	15
32	2018	Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Luo, Nan ; Bonsel, Gouke J ; Janssen, Mathieu F. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8. Full description at Econpapers \|\| Download paper	14
33	2013	Operationalizing Value-Based Pricing of Medicines. (2013). Towse, Adrian ; Devlin, Nancy ; Sussex, Jon. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:1-10. Full description at Econpapers \|\| Download paper	14
34	2018	Discounting in Economic Evaluations. (2018). Claxton, Karl ; Brouwer, Werner ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z. Full description at Econpapers \|\| Download paper	14
35	2014	Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010. (2014). Klemp, Marianne ; Olsen, Jan ; Hagen, Gunhild ; Movik, Espen ; Hamidi, Vida ; Wisloff, Torbjorn. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:367-375. Full description at Econpapers \|\| Download paper	14
36	2010	Using Conjoint Analysis and Choice Experiments to Estimate QALY Values. (2010). Flynn, Terry. In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:9:p:711-722. Full description at Econpapers \|\| Download paper	14
37		Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Muszbek, Noemi ; Ishak, K. ; Benedict, Agnes. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675. Full description at Econpapers \|\| Download paper	13
38		The Impact of the Urban Resident Basic Medical Insurance on Health Services Utilisation in China. (2014). Chen, Gang ; Liu, Gordon ; Xu, Fei. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:3:p:277-292. Full description at Econpapers \|\| Download paper	13
39	2012	Losing Sight of the Wood for the Trees. (2012). Peasgood, Tessa ; Dolan, Paul ; Lee, Henry. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:11:p:1035-1049. Full description at Econpapers \|\| Download paper	13
40	2018	Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues. (2018). Danzon, Patricia. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0696-4. Full description at Econpapers \|\| Download paper	13
41	2006	Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996â2003. (2006). Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin ; Liu, Chien-Hsiang ; Lee, Yue-Chune. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902. Full description at Econpapers \|\| Download paper	12
42	2019	Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. (2019). Deshpande, Abhishek ; Zhang, LU ; Nghiem, Van T ; Chiyaka, Edward T ; Le, Phuc ; Mullen, Patricia Dolan. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0735-1. Full description at Econpapers \|\| Download paper	12
43	2007	Rates and Probabilities in Economic Modelling. (2007). Fleurence, Rachael ; Hollenbeak, Christopher . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:1:p:3-6. Full description at Econpapers \|\| Download paper	12
44	2016	Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial. (2016). Kim, Jane J ; Verguet, Stephane ; Jamison, Dean T. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0414-z. Full description at Econpapers \|\| Download paper	12
45	2006	Using Discrete Choice Experiments within a Cost-Benefit Analysis Framework. (2006). McIntosh, Emma. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:855-868. Full description at Econpapers \|\| Download paper	12
46	2008	Cost-Effectiveness Analyses of Vaccination Programmes. (2008). Kim, Sun-Young ; Goldie, Sue. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:3:p:191-215. Full description at Econpapers \|\| Download paper	12
47	1997	Guidelines for Pharmacoeconomic Studies. (1997). Russell, Louise ; Siegel, Joanna ; Torrance, George ; Luce, Bryan ; Weinstein, Milton ; Gold, Marthe . In: PharmacoEconomics. RePEc:spr:pharme:v:11:y:1997:i:2:p:159-168. Full description at Econpapers \|\| Download paper	11
48	2000	Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio. (2000). Montmartin, Jacques ; Stevens, John ; OHagan, Anthony . In: PharmacoEconomics. RePEc:spr:pharme:v:17:y:2000:i:4:p:339-349. Full description at Econpapers \|\| Download paper	11
49	2006	Generic Health-Related Quality-of-Life Assessment in Children and Adolescents. (2006). Wille, Nora ; Bullinger, Monika ; Erhart, Michael ; Nickel, Jennifer ; Ravens-Sieberer, Ulrike ; Wetzel, Ralf. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:12:p:1199-1220. Full description at Econpapers \|\| Download paper	11
50	2016	From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare. (2016). Brouwer, Werner ; Knies, Saskia ; Versteegh, Matthijs. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:11:d:10.1007_s40273-016-0431-y. Full description at Econpapers \|\| Download paper	11

50 most relevant documents in this series (papers most cited in the last two years)

#	Year	Title	Cited
1	2019	Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Vass, Caroline ; Ellis, Alan R ; Bekker-Grob, Esther W ; Soekhai, Vikas. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2. Full description at Econpapers \|\| Download paper	37
2	2008	Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers \|\| Download paper	32
3	2014	Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino ; Moro, Domenico ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902. Full description at Econpapers \|\| Download paper	23
4	2016	Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9. Full description at Econpapers \|\| Download paper	22
5	2013	Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Greenberg, Dan ; Carswell, Chris ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. Full description at Econpapers \|\| Download paper	21
6	2015	The Epidemiology of Obesity: A Big Picture. (2015). Hruby, Adela ; Hu, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:673-689. Full description at Econpapers \|\| Download paper	20
7	2017	Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4. Full description at Econpapers \|\| Download paper	16
8	2018	A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D. (2018). Feng, You-Shan ; Kohlmann, Thomas ; Janssen, Mathieu F ; Buchholz, Ines. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0642-5. Full description at Econpapers \|\| Download paper	11
9	2015	The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Suhrcke, Marc ; Archangelidi, Olga ; Seuring, Till. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831. Full description at Econpapers \|\| Download paper	11
10	2013	How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119. Full description at Econpapers \|\| Download paper	9
11	2016	EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark ; Luo, Nan. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1. Full description at Econpapers \|\| Download paper	9
12	2018	German Value Set for the EQ-5D-5L. (2018). Graf von der Schulenburg, Johann ; Greiner, Wolfgang ; J-Matthias Graf von der Schulenburg, ; Ludwig, Kristina. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8. Full description at Econpapers \|\| Download paper	8
13	2019	Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. (2019). Deshpande, Abhishek ; Zhang, LU ; Nghiem, Van T ; Chiyaka, Edward T ; Le, Phuc ; Mullen, Patricia Dolan. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0735-1. Full description at Econpapers \|\| Download paper	8
14	2018	Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Luo, Nan ; Bonsel, Gouke J ; Janssen, Mathieu F. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8. Full description at Econpapers \|\| Download paper	8
15	2014	Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965. Full description at Econpapers \|\| Download paper	7
16	2018	Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues. (2018). Danzon, Patricia. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0696-4. Full description at Econpapers \|\| Download paper	7
17	2021	The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018). (2021). Simes, Mark ; Sisitsky, Tammy ; Fournier, Andree-Anne ; Greenberg, Paul E ; Kessler, Ronald C ; Koenigsberg, Sarah H ; Berman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01019-4. Full description at Econpapers \|\| Download paper	6
18	2022	A Value Set for the EQ-5D-Y-3L in the Netherlands. (2022). Finch, Aureliano Paolo ; Stalmeier, Peep ; Lipman, Stefan ; Essers, Brigitte ; Sajjad, Ayesha ; Roudijk, Bram. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01192-0. Full description at Econpapers \|\| Download paper	5
19	2014	A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170. Full description at Econpapers \|\| Download paper	5
20	2018	Discounting in Economic Evaluations. (2018). Claxton, Karl ; Brouwer, Werner ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z. Full description at Econpapers \|\| Download paper	5
21	2021	What are the Economic Costs to Society Attributable to Alcohol Use? A Systematic Review and Modelling Study. (2021). Kilian, Carolin ; Carr, Sinclair ; Hassan, Syed Ahmed ; Manthey, Jakob ; Rehm, Jurgen ; Kuitunen-Paul, Soren. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:7:d:10.1007_s40273-021-01031-8. Full description at Econpapers \|\| Download paper	5
22	2018	Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Cheng, Terence ; Ali, Hossein Haji ; Edney, Laura Catherine ; Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2. Full description at Econpapers \|\| Download paper	5
23	2019	Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe. (2019). Niewada, Maciej ; Graczyk, Katarzyna ; Jakubczyk, Micha ; Golicki, Dominik. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:9:d:10.1007_s40273-019-00811-7. Full description at Econpapers \|\| Download paper	5
24	2022	Value Set for the EQ-5D-Y-3L in Hungary. (2022). Brodszky, Valentin ; Finch, Aureliano Paolo ; Yang, Zhihao ; Bato, Alex ; Ruzsa, Gabor ; Rencz, Fanni. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01190-2. Full description at Econpapers \|\| Download paper	5
25	2017	Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature. (2017). Krahn, Murray ; Fenwick, Elisabeth ; Koffijberg, Hendrik ; Ijzerman, Maarten J. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0509-1. Full description at Econpapers \|\| Download paper	5
26	2014	How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. Full description at Econpapers \|\| Download paper	5
27	2019	The Use of Risk-Sharing Contracts in Healthcare: Theoretical and Empirical Assessments. (2019). Rodriguez-Ibeas, Roberto ; Lorente, Reyes ; Juarez-Castello, Carmelo ; Antonanzas, Fernando. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:12:d:10.1007_s40273-019-00838-w. Full description at Econpapers \|\| Download paper	5
28	2019	One Method, Many Methodological Choices: A Structured Review of Discrete-Choice Experiments for Health State Valuation. (2019). Viney, Rosalie ; Street, Deborah J ; Norman, Richard ; Mulhern, Brendan. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:1:d:10.1007_s40273-018-0714-6. Full description at Econpapers \|\| Download paper	4
29	2011	Cost-of-Illness Studies. (2011). Moss, John ; Larg, Allison . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:8:p:653-671. Full description at Econpapers \|\| Download paper	4
30	2011	Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33. Full description at Econpapers \|\| Download paper	4
31	2020	Talkinâ About a Resolution: Issues in the Push for Greater Transparency of Medicine Prices. (2020). Mestre-Ferrandiz, Jorge ; Shaw, Brendan. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:2:d:10.1007_s40273-019-00877-3. Full description at Econpapers \|\| Download paper	4
32	2022	Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. (2022). Staniszewska, Sophie ; Bekker-Grob, Esther ; Pwu, Raoh-Fang ; Augustovski, Federico ; Petrou, Stavros ; Drummond, Michael ; Mullins, Daniel C ; Husereau, Don ; Mauskopf, Josephine ; Loder, Elizabeth ; Greenberg, Dan ; Chaiyakunapruk, Nathorn ; Caulley, Lisa ; Carswell, Chris ; Briggs, Andrew H. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:6:d:10.1007_s40273-021-01112-8. Full description at Econpapers \|\| Download Combining the Power of Artificial Intelligence with the Richness of Healthcare Claims Data: Opportunities and Challenges. (2019). Sraer, David ; Greenberg, Paul ; Thesmar, David ; Veliche, Razvan ; Dadson, Nick ; Pinheiro, Lisa. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:6:d:10.1007_s40273-019-00777-6. Full description at Econpapers \|\| Download paper	4
34	2017	The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta ; Oliva-Moreno, Juan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y. Full description at Econpapers \|\| Download paper	4
35	2017	International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Hout, Ben ; Chevrou-Severac, Helene ; Zouraq, Ismail Azzabi ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y. Full description at Econpapers \|\| Download paper	4
36	2015	Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Arnberg, Karl ; Nilsson, Fredrik. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236. Full description at Econpapers \|\| Download paper	4
37	2020	Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines. (2020). Federici, Carlo ; Dams, Florian ; Ciani, Oriana ; Grigore, Bogdan ; Taylor, Rod S ; Zemplenyi, Antal ; Shatrov, Kosta ; Rabbe, Stefan ; Mollenkamp, Meilin ; Groot, Saskia. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:10:d:10.1007_s40273-020-00935-1. Full description at Econpapers \|\| Download paper	4
38	2020	Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?. (2020). Devlin, Nancy ; Rivero-Arias, Oliver ; Rowen, Donna ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:4:d:10.1007_s40273-019-00873-7. Full description at Econpapers \|\| Download paper	4
39	2006	Generic Health-Related Quality-of-Life Assessment in Children and Adolescents. (2006). Wille, Nora ; Bullinger, Monika ; Erhart, Michael ; Nickel, Jennifer ; Ravens-Sieberer, Ulrike ; Wetzel, Ralf. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:12:p:1199-1220. Full description at Econpapers \|\| Download paper	4
40	2015	A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE). (2015). Viney, Rosalie ; Feeny, David ; Devlin, Nancy ; Krabbe, Paul ; Pickard, A ; Xie, Feng ; Revicki, Dennis. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:867-877. Full description at Econpapers \|\| Download paper	3
41	2015	A Primer on Marginal EffectsâPart I: Theory and Formulae. (2015). Bergtold, Jason ; Jain, Rahul ; Onukwugha, Eberechukwu. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:1:p:25-30. Full description at Econpapers \|\| Download paper	3
42	2016	Are Efficient Designs Used in Discrete Choice Experiments Too Difficult for Some Respondents? A Case Study Eliciting Preferences for End-of-Life Care. (2016). Flynn, Terry N ; Finkelstein, Eric A ; Malhotra, Chetna ; Bilger, Marcel. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:3:d:10.1007_s40273-015-0338-z. Full description at Econpapers \|\| Download paper	3
43	2017	Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?. (2017). Vass, Caroline ; Payne, Katherine. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0518-0. Full description at Econpapers \|\| Download paper	3
44	2021	EQ-5D-Y Value Set for Slovenia. (2021). Ogorevc, Marko ; Rupel, Valentina Prevolnik. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:4:d:10.1007_s40273-020-00994-4. Full description at Econpapers \|\| Download paper	3
45	2018	Cost-Effectiveness Thresholds: the Past, the Present and the Future. (2018). Tong, Thaison ; Leech, Ashley A ; Ochalek, Jessica ; Thokala, Praveen. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:5:d:10.1007_s40273-017-0606-1. Full description at Econpapers \|\| Download paper	3
46	2014	Preferences for Oral Anticoagulants in Atrial Fibrillation: a BestâBest Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127. Full description at Econpapers \|\| Download paper	3
47	2020	Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States. (2020). Leidl, Reiner ; Gerdtham, Ulf-G. ; Ulf- G. Gerdtham, ; Teni, Fitsum Sebsibe ; Burstrom, Kristina ; Henriksson, Martin ; Rolfson, Ola ; Helgesson, Gert ; Ulf-G. Gerdtham, . In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00905-7. Full description at Econpapers \|\| Download paper	3
48	2018	Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review. (2018). , John ; John , ; Thayer, Winter Maxwell ; Zhou, MO. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0575-4. Full description at Econpapers \|\| Download paper	3
49	2014	Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime ; Neasham, David ; Lanitis, Tereza . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365. Full description at Econpapers \|\| Download paper	3
50	2019	Spillover Effects on Caregiversâ and Family Membersâ Utility: A Systematic Review of the Literature. (2019). Prosser, Lisa A ; James, Lyndon P ; Wittenberg, Eve. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00768-7. Full description at Econpapers \|\| Download paper	3

Citing documents used to compute impact factor: 23

Year	Title
2023
2023	Informal caregiving and the allocation of time: implications for opportunity costs and measurement. (2023). Sutton, Matthew ; Grande, Gunn ; Lau, Yiu-Shing ; Urwin, Sean. In: Social Science & Medicine. RePEc:eee:socmed:v:334:y:2023:i:c:s027795362300521x. Full description at Econpapers \|\| Download paper
2023	. Full description at Econpapers \|\| Download paper
2023	. Full description at Econpapers \|\| Download paper
2023	Productivity and quality-adjusted life years: QALYs, PALYs and beyond. (2023). Moreno-Ternero, Juan ; Hansen, Kristian S ; Osterdal, Lars P. In: Working Papers. RePEc:hhs:cbsnow:2023_011. Full description at Econpapers \|\| Download paper
2023	Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology. (2023). Attema, Arthur ; Shah, Koonal K ; Zhang, Liying ; Lipman, Stefan A. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01466-6. Full description at Econpapers \|\| Download paper
2023	. Full description at Econpapers \|\| Download paper
2023	Assessing the treatment pattern, health care resource utilisation, and economic burden of multiple myeloma in France using the SystÃ¨me National des DonnÃ©es de SantÃ© (SNDS) database: a retrospective co. (2023). Sapra, Sandhya ; Willson, Jenny ; Sansbury, Leah ; Gutierrez, Benjamin ; Gorsh, Boris ; Ferrante, Shannon ; Sopwith, Will ; de Nascimento, Julie ; Colin, Xavier ; Wang, Feng ; Bessou, Antoine ; Paka, Prani. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:3:d:10.1007_s10198-022-01463-9. Full description at Econpapers \|\| Download Marijuana Legalization and Mental Health. (2023). Romiti, Agnese ; Norris, Jonathan ; Lenhart, Otto ; Borbely, Daniel. In: Working Papers. RePEc:str:wpaper:2302. Full description at Econpapers \|\| Download paper
2023	. Full description at Econpapers \|\| Download paper
2023	Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2? Metastatic Breast Cancer in Postmenopausal Women in the USA. (2023). Trivedi, Meghana V ; Deshmukh, Ashish A ; Damgacioglu, Haluk ; Masurkar, Prajakta P. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:6:d:10.1007_s40273-023-01245-y. Full description at Econpapers \|\| Download paper
2023	. Full description at Econpapers \|\| Download paper
2023	Excess costs of multiple sclerosis: a register-based study in Sweden. (2023). Tinghog, Petter ; Murley, Chantelle ; Friberg, Emilie ; Karampampa, Korinna ; Hillert, Jan ; Alexanderson, Kristina ; Machado, Alejandra ; Teni, Fitsum Sebsibe. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:8:d:10.1007_s10198-022-01547-6. Full description at Econpapers \|\| Download paper
2023	Guidance on the use of complex systems models for economic evaluations of public health interventions. (2023). Lomax, Nik ; Alava, Monica Hernandez ; Paisley, Suzy ; Hayes, Kate ; Cookson, Richard ; Strong, Mark ; Meier, Petra ; Brennan, Alan ; Kadirkamanathan, Visakan ; Dodd, Peter J ; Ennis, Kate ; Walsh, Cathal ; Boyd, Jennifer ; Robinson, Stewart ; Squires, Hazel ; Vale, Luke ; Smith, Robert ; Purshouse, Robin ; Breeze, Penny R ; Silverman, Eric ; Bayley, Thomas ; Gilbert, Nigel ; Siebert, Uwe ; Lawson, Kenny ; Oflaherty, Martin ; Scarborough, Peter ; Occhipinti, Joan ; de Vocht, Frank ; Sassi, Franco ; Shahab, Lion ; Kee, Frank ; Karapici, Amanda ; Briggs, Andrew ; Shiell, Alan ; Jackson, Christopher H. In: Health Economics. RePEc:wly:hlthec:v:32:y:2023:i:7:p:1603-1625.
2023	Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands. (2023). Husbands, Samantha ; Hiligsmann, Mickael ; Morton, Rachael L ; Mitchell, Paul Mark ; Coast, Joanna. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:4:d:10.1007_s10198-022-01498-y. Full description at Econpapers \|\| Download paper
2023
2023	Trade Union Membersâ Experiences and Attitudes towards Working from Home during the Pandemic. (2023). Garzia, Christine ; Debono, Manwel. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:3:p:1953-:d:1041653. Full description at Econpapers \|\| Download paper
2023	A koronavÃrus-jÃ¡rvÃ¡ny a kÃ¶zgazdasÃ¡gi szakirodalomban. Egy Ãºj hatÃ¡rterÃ¼let tudomÃ¡nymetriai elemzÃ©se. (2023). Nagy, Andrea Magda ; Konka, Boglarka ; Torok, Adam. In: KÃ¶zgazdasÃ¡gi Szemle (Economic Review - monthly of the Hungarian Academy of Sciences). RePEc:ksa:szemle:2111. Full description at Econpapers \|\| Download paper
2023	. Full description at Econpapers \|\| Download paper
2023	. Full description at Econpapers \|\| Download paper
2023	. Full description at Econpapers \|\| Download paper
2023	The Impact of Digital Health Interventions for the Management of Type 2 Diabetes on Health and Social Care Utilisation and Costs: A Systematic Review. (2023). Gomes, Manuel ; Li, Keyi ; Ledger, Jean ; Aspinal, Fiona ; Morris, Tiyi. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:2:d:10.1007_s41669-022-00377-9. Full description at Econpapers \|\| Download paper
2023	Including Young Children in the Development and Testing of Patient Reported Outcome (PRO) Instruments: A Scoping Review of Childrenâs Involvement and Qualitative Methods. (2023). Carlton, Jill ; Gale, Victoria. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:16:y:2023:i:5:d:10.1007_s40271-023-00637-8. Full description at Econpapers \|\| Download paper

Recent citations

Recent citations received in 2023

Year	Citing document
2023	Values in Modelling: Video Series Development and Evaluation Survey. (2023). Murphy, David ; Adibi, Amin ; McLean, Alison ; Werker, Greg ; Easterbrook, Adam ; Harvard, Stephanie. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:21:y:2023:i:5:d:10.1007_s40258-023-00820-w. Full description at Econpapers \|\| Download paper
2023	Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States. (2023). Reginster, Jean-Yves ; Caminis, John ; Wang, Yamei ; Mathew, Jake ; Pearman, Leny ; Singer, Andrea J ; Silverman, Stuart S ; Hiligsmann, Mickael. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:7:d:10.1007_s40273-023-01270-x. Full description at Econpapers \|\| Download paper

Recent citations received in 2022

Year	Citing document
2022	Where do measures of health, social care and wellbeing fit within a wider measurement framework? Implications for the measurement of quality of life and the identification of bolt-ons. (2022). Mulhern, Brendan ; Finch, Aureliano Paolo. In: Social Science & Medicine. RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622006761. Full description at Econpapers \|\| Download paper
2022	The health cost of reducing hospital bed capacity. (2022). Henriksson, Martin ; Siverskog, Jonathan. In: Social Science & Medicine. RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622007055. Full description at Econpapers \|\| Download paper
2022	. Full description at Econpapers \|\| Download paper
2022	. Full description at Econpapers \|\| Download paper
2022	Response to Comment on âAn Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophreniaâ. (2022). Wang, Xiaofeng ; Kraan, Carla W ; Houwing, Natalie ; Piena, Marjanne A ; Bennison, Craig ; Waters, Heidi. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:12:d:10.1007_s40273-022-01213-y. Full description at Econpapers \|\| Download paper
2022	An EQ-5D-Y-3L Value Set for Belgium. (2022). Ramos-Goi, Juan M ; Tollenaar, Nafthali H ; Roudijk, Bram ; Dewilde, Sarah. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01187-x. Full description at Econpapers \|\| Download paper
2022	Value Set for the EQ-5D-Y-3L in Hungary. (2022). Brodszky, Valentin ; Finch, Aureliano Paolo ; Yang, Zhihao ; Bato, Alex ; Ruzsa, Gabor ; Rencz, Fanni. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01190-2. Full description at Econpapers \|\| Download paper
2022	Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L. (2022). Rivero-Arias, Oliver ; Shah, Koonal K ; Norman, Richard ; Kreimeier, Simone ; Devlin, Nancy J ; Mott, David J. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01214-x. Full description at Econpapers \|\| Download paper
2022	Estimating an EQ-5D-Y-3L Value Set for China. (2022). Jing, Mingxia ; Li, Shunping ; Yu, Xiao ; Feng, DA ; Fang, YU ; Wu, Jing ; Wang, Pei ; Luo, Nan ; Jiang, Jie ; Huang, Weidong ; Yang, Zhihao ; Zheng, Bin. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01216-9. Full description at Econpapers \|\| Download paper
2022	Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L. (2022). Gu, Ning Yan ; Pickard, Simon A ; Nazari, Jonathan L. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01222-x. Full description at Econpapers \|\| Download paper
2022	EQ-5D-Y-3L Value Sets, Valuation Methods and Conceptual Questions. (2022). Stolk, Elly ; Viney, Rosalie ; Roudijk, Bram ; Devlin, Nancy. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01226-7. Full description at Econpapers \|\| Download paper
2022	Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China. (2022). Chen, Yixuan ; Li, Huangqianyu ; Wei, Yuxuan ; Zhang, Yichen ; Guan, Xiaodong ; Shi, Luwen ; Guo, Yiran. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:7:d:10.1007_s40273-022-01161-7. Full description at Econpapers \|\| Download paper

Recent citations received in 2021

Year	Citing document
2021	Value judgments in a COVID-19 vaccination model: A case study in the need for public involvement in health-oriented modelling. (2021). Adibi, Amin ; Symons, John ; Winsberg, Eric ; Harvard, Stephanie. In: Social Science & Medicine. RePEc:eee:socmed:v:286:y:2021:i:c:s0277953621006559. Full description at Econpapers \|\| Download paper
2021	. Full description at Econpapers \|\| Download paper
2021	. Full description at Econpapers \|\| Download paper
2021	. Full description at Econpapers \|\| Download paper
2021	. Full description at Econpapers \|\| Download paper
2021	The Health and Productivity Burden of Depression in South Korea. (2021). Ademi, Zanfina ; Liew, Danny ; Rhee, Yongjoo ; Zomer, Ella. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:6:d:10.1007_s40258-021-00649-1. Full description at Econpapers \|\| Download paper
2021	EQ-5D-Y Population Norms for Japanese Children and Adolescents. (2021). Fukuda, Takashi ; Shiroiwa, Takeru. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:11:d:10.1007_s40273-021-01063-0. Full description at Econpapers \|\| Download paper
2021	Health-Economic Analyses of Diagnostics: Guidance on Design and Reporting. (2021). Postma, Maarten J ; Villar, Fernando Antoanzas ; Garcia, Paula Rojas ; Pol, Simon. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:12:d:10.1007_s40273-021-01104-8. Full description at Econpapers \|\| Download paper
2021	Authorsâ Reply to Comment on âCost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndromeâ. (2021). Veenstra, David L ; Carlson, Josh J ; Neuberger, Edward E. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:4:d:10.1007_s40273-021-01006-9. Full description at Econpapers \|\| Download paper
2021	Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States. (2021). Bright, Jennifer L ; Linthicum, Mark T ; Malik, Erica Defur ; Xie, Richard Z. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01036-3. Full description at Econpapers \|\| Download paper
2021	The Growing Burden of Major Depressive Disorders (MDD): Implications for Researchers and Policy Makers. (2021). Nellesen, Dave ; Greenberg, Paul ; Proudman, David. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01040-7. Full description at Econpapers \|\| Download paper

Recent citations received in 2020

Year	Citing document
2020	Health Economics Tools and Precision Medicine: Opportunities and Challenges. (2020). Scott, Ramsey ; Josh, Peterson ; Peter, Neumann ; Jeanne, Mandelblatt ; Anirban, Basu ; David, Veenstra. In: Forum for Health Economics & Policy. RePEc:bpj:fhecpo:v:23:y:2020:i:1:p:14:n:1. Full description at Econpapers \|\| Download paper
2020
2020	Systematic review of the methods of health economic models assessing antipsychotic medication for schizophrenia. (2020). Byford, Sarah ; Aceituno, David ; Achilla, Evanthia ; Robinson, Stewart ; Tappenden, Paul ; Jin, Huajie. In: PLOS ONE. RePEc:plo:pone00:0234996. Full description at Econpapers \|\| Download paper
2020	Stakeholder-Engaged Derivation of Patient-Informed Value Elements. (2020). Dosreis, Susan ; Slejko, Julia F ; Zhang, Chengchen ; Hong, Yoon Duk ; Kennedy, Annie ; Caicedo, Juan ; Butler, Beverly. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:13:y:2020:i:5:d:10.1007_s40271-020-00433-8. Full description at Econpapers \|\| Download paper
2020	External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions. (2020). Johansen, Pierre ; Lamotte, Mark ; Lopes, Sandra ; Foos, Volker ; Olivieri, Anamaria-Vera ; McEwan, Phil. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:10:d:10.1007_s40273-020-00941-3. Full description at Econpapers \|\| Download paper
2020	Reflections on NICEâs Uptake of New Methods: Past, Present, and the 2020 Review. (2020). Watson, Ian ; Boysen, Meindert. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-020-00888-5. Full description at Econpapers \|\| Download paper
2020	Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of BestâWorst Scaling. (2020). Gorostiza, Inigo ; Garcia-Lorenzo, Borja ; Catchpool, Max ; Dalziel, Kim ; Rivero-Arias, Oliver ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:5:d:10.1007_s40273-020-00884-9. Full description at Econpapers \|\| Download paper
2020	Response to Comment on âFluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-Infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisalâ. (2020). Denniston, Alastair K ; Carrera, Vanesa Huertas ; Joore, Manuela A ; Petersohn, Svenja ; Kleijnen, Jos ; Riemsma, Rob ; Noake, Caro ; Worthy, Gill ; Witlox, Willem ; Armstrong, Nigel ; Raatz, Heike ; Chalker, Annette. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:6:d:10.1007_s40273-020-00900-y. Full description at Econpapers \|\| Download Replacing the NCCNâs Blocks with Wheels: How Should Consideration of Societal Spending be Incorporated into Oncology Practice?. (2020). Prasad, Vinay ; Tran, Audrey A. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00920-8. Full description at Econpapers \|\| Download paper
2020	What Value Does the NCCN Affordability Rating Really Provide to Patients, Providers, and Society?. (2020). McQueen, Brett R. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00924-4. Full description at Econpapers \|\| Download paper
2020	Why itâs Time to Abandon the ICER. (2020). Paulden, Mike. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00915-5. Full description at Econpapers \|\| Download paper
2020	Does Cost-Effectiveness Analysis Really Need to Abandon the Incremental Cost-Effectiveness Ratio to Embrace Net Benefit?. (2020). Omahony, James F. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00931-5. Full description at Econpapers \|\| Download paper
2020	Keeping Pace with Pharmaceutical Innovation: The Importance of the NICE Methods Review. (2020). Barrett, Victoria ; Catchpole, Paul. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:9:d:10.1007_s40273-020-00918-2. Full description at Econpapers \|\| Download paper
2020	Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review. (2020). Mattingly, T. Joseph ; Khokhar, Bilal ; Love, Bryan L. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:9:d:10.1007_s40273-020-00933-3. Full description at Econpapers \|\| Download paper

10 most frequent citing series

#	Series	H	Cites
1	The European Journal of Health Economics / Springer	29	347
2			298
3	PharmacoEconomics / Springer	19	167
4	Social Science & Medicine / Elsevier	75	160
5	PLOS ONE / Public Library of Science	54	124
6	Health Economics / John Wiley & Sons, Ltd.	76	123
7	Health Policy / Elsevier	37	88
8	Applied Health Economics and Health Policy / Springer	14	34
9	Journal of choice modelling / Elsevier	19	28
10	Journal of Health Economics / Elsevier	123	22
11	PharmacoEconomics - Open / Springer	5	22